![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | (2006.01) |
A61K 38/08 | (2013.01) | ||
A61K 31/337 | (2006.01) | ||
C07K 7/06 | (2013.01) | ||
A61K 33/243 | (2019.01) | ||
A61K 45/06 | (2013.01) | ||
A61K 38/08 | (2006.01) | ||
A61K 31/337 | (2013.01) | ||
C07K 7/06 | (2006.01) | ||
A61K 33/243 | (2019.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/04 | (2006.01) | ||
A61P 35/04 | (2018.01) |
(11) | Number of the document | 3411058 |
(13) | Kind of document | T |
(96) | European patent application number | 17747995.3 |
Date of filing the European patent application | 2017-01-31 | |
(97) | Date of publication of the European application | 2018-12-12 |
(45) | Date of publication and mention of the grant of the patent | 2023-03-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/015754 |
Date | 2017-01-31 |
(87) | Number | WO 2017/136312 |
Date | 2017-08-10 |
(30) | Number | Date | Country code |
201662290306 P | 2016-02-02 | US | |
201662314867 P | 2016-03-29 | US | |
201662368964 P | 2016-07-29 | US |
(72) |
FINLAYSON, Malcolm , US
NELSON, David , US
|
(73) |
Splash Pharmaceuticals, Inc. ,
4365 Executive Drive
Suite 1500, San Diego, CA 92121,
US
|
(54) | COMBINATION THERAPY WITH A6 AND PACLITAXEL FOR THE TREATMENT OF OVARIAN CANCER |
COMBINATION THERAPY WITH A6 AND PACLITAXEL FOR THE TREATMENT OF OVARIAN CANCER |